Rho kinase inhibitors are a class of drugs that target the Rho-associated protein kinase pathway, which plays a crucial role in regulating vascular tone, cell proliferation, and apoptosis. They have potential therapeutic applications in treating cardiovascular diseases, glaucoma, and certain cancers by modulating these biological processes.